1. Obstetric aspects of the use in pregnancyassociated hypertension of the beta-adrenoceptor antagonist atenolol;Rubin, P.C.; Butters, L.; Clark, D.M.;AmJi Obstet Gvnecol,1984
2. The first year of life after use of atenolol in pregnancy associated hypertension;Reynolds, B.; Butters, L.; Evans, J.; Adam, T.; Rubin, P.C.;Arch Dis Child,1984
3. Maternal beta-adrenoceptor blockade reduces fetal tolerance to asphyxia;Kjellmer, I.; Dagbiartsson, A.; Hrebk, A.; Karlsson, K.; Rosen, K.-G.;Acta Obstet GvnecolScand,1984
4. The acute effects of non-selective l-adrenergic blocking agents in hypertensive rats;Karlsson, K.; Lundgren, Y.; Ljungblad, U.;Acta Obstet Gynecol Scand,1984
5. Fetal and uteroplacental haemodynamics during short term atenolol treatment of hypertension in pregnancy;Montan, S.; Liedholm, H.; Lingman, G.; Marsal, K.; Sjiberg, N.-O.; Solum, T.;BrJ Obstet Gynaecol,1987